Stock XENE XENON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Xenon Pharmaceuticals Inc.

Equities

XENE

CA98420N1050

Real-time Estimate Cboe BZX
Other stock markets
 01:36:20 2024-06-11 pm EDT 		5-day change 1st Jan Change
37.73 USD -1.33% Intraday chart for Xenon Pharmaceuticals Inc. -1.05% -18.15%
Jun. 04 Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call
May. 28 Xenon Pharmaceuticals Inc. Presents Data from Phase 2 X-Nova Clinical Trial of Azetukalner in Major Depressive Disorder At the American Society of Clinical Psychopharmacology 2024 Annual Meeting CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GL
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
GL
Encephalopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
Xenon Pharmaceuticals: Q1 Earnings Snapshot
AQ
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
GL
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GL
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
GL
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
GL
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
GL
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
GL
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
GL
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
AQ
Xenon Pharmaceuticals : Alberta Securities Commission British Columbia Securities Commission Ontario Securities Commission - Form 8-K
PU
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
GL
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
AQ
Xenon Pharmaceuticals: Q4 Earnings Snapshot
AQ
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GL
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XENE Stock
  4. News Xenon Pharmaceuticals Inc.
  5. Press Releases